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Background: The utility of definitive radiotherapy (RT) for locoregionally advanced squamous cell carcinoma (SCC)
of the larynx or hypopharynx in the setting of thyroid or cricoid cartilage invasion (TCCI) is controversial. A
retrospective review of our experience was performed.
Methods: Our institutional database of patients with SCC of the head and neck treated with radiotherapy (90%
received concurrent systemic therapy) between 1995 and 2009 was queried. We identified 87 patients with T3-4
laryngeal or T4 hypopharyngeal cancer for whom initial head and neck imaging was available for review. Imaging
of all patients was reviewed by a single radiologist specializing in neuroradiology. The presence and extent of TCCI
was determined and used for stratification.
Results: Median follow-up was 34 months. TCCI was found in 25 (29%) patients, eight limited to the inner cortex
and another 17 involving both cortices. Local control (LC) was not significantly affected by TCCI limited to the inner
cortex. However, TCCI involving both cortices was correlated with diminished LC at 2 years compared to the group
of patients with no or minor invasion (55% vs. 81%, p=0.045). However, TCCI involving both cortices was not
associated with significantly reduced rates of survival with a functional larynx, or overall survival (OS).
Conclusions: Our results suggest that the rate of LC of T3-4 laryngeal or T4 hypopharyngeal SCC treated with
definitive RT is not affected by TCCI of the inner cortex. Although decreased LC was significantly associated with
TCCI involving both cortices, this factor did not appear to result in reduced rates of survival with a functional larynx
or OS. Therefore, organ preservation may remain an option in these patients.
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Patients with thyroid or cricoid cartilage invasion
(TCCI) of the larynx were included in the landmark
Veteran’s Administration (VA) Laryngeal Cancer Study
Group trial which established the effectiveness of organ
preservation for advanced laryngeal cancer using a regi-
men of induction cisplatin and 5-fluorouracil followed
by radiotherapy (RT) [1]. Although there was a higher* Correspondence: gesims@uabmc.edu
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reproduction in any medium, provided the orrate of salvage laryngectomy in patients with gross cartil-
age invasion, this difference was not significant. How-
ever, T4 tumors in general had a 59% risk of salvage
laryngectomy, significantly higher than smaller tumors.
The EORTC trial 24891 also tested a similar organ pres-
ervation scheme for locally advanced tumors of the
pyriform sinus [2]. None of the four T4 patients rando-
mized to induction chemotherapy achieved a complete
response and were therefore diverted to definitive
surgery.
Based on the findings of the VA and EORTC trials, the
RTOG chose to exclude high volume T4 tumors in its
largest laryngeal preservation trial, 91–11. High volumel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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extending more than 1 cm into the base of the tongue
[3]. In contrast, several European groups continued to
include T4 lesions of the larynx and hypopharynx in
organ preservation trials [4-7]. Given the uncertainty
regarding feasibility of organ preservation in T4 laryn-
geal or hypopharyngeal cancers with TCCI, we retro-
spectively examined outcomes for this population at the
University of Alabama at Birmingham.Methods
The University of Alabama at Birmingham Department
of Radiation Oncology database of patients with squa-
mous cell carcinoma (SCC) of the head and neck treated
with definite radiotherapy between 1995 and 2009 was
queried. Patients were included in this study whose
AJCC staging criteria (version 6.0) incorporated TCCI
(T3-4 laryngeal SCC or T4 hypopharyngeal SCC), were
18 years old or older, received definitive radiotherapy
(RT), and had pretreatment imaging of the neck with ei-
ther computed tomography (CT) or magnetic resonance
imaging (MRI) that was available for review. Eighty-
seven patients remained for analysis. These patients did
not undergo surgery due to various reasons. Patients
were reviewed at a multidisciplinary conference and
their preferences as well as co-morbidities were consid-
ered. Of the 87 patients, 27 were treated on chemora-
diotherapy protocols.
A single radiologist (JKC), who specializes in neurora-
diology, performed a detailed review of pre-treatment
neck imaging to determine the presence or absence of
TCCI. The extent of TCCI was further characterized as
limited to the inner cortex (henceforth “minor TCCI”)
or invading into both inner and outer cortices with or
without extralaryngeal spread (henceforth “major TCCI”).
Examples are shown in Figure 1. Patients judged to
solely have sclerosis of the cartilage or extralaryngealFigure 1 Illustration and CT images of major (left) and minor
(right) thyroid or cricoid cartilage invasion (TCCI). The AJCC 7th
edition staging manual for laryngeal tumors classifies minor TCCI
(i.e. invasion limited to the inner cortex) as T3 and major invasion
(i.e. invasion into both inner and outer cortices) as T4. Both minor
and major TCCI are staged as T4 for hypopharyngeal tumors.spread without cartilage invasion were not considered to
have TCCI.
Treatment techniques for this patient population have
been reported previously [8]. Briefly, all patients were
immobilized with a thermoplastic head and neck mask
and underwent CT simulation. Patients were planned
using 3-dimensional treatment planning or intensity
modulated radiation therapy (IMRT) with 6-megavolt
photons. In this group of 87 patients, 16 patients had
tracheostomies prior to radiation and this procedure was
primarily performed for stabilization of the airway. In-
duction and concurrent chemotherapy consisted of a
platinum agent with or without a taxane or fluorouracil.
The anti-EGFR monoclonal antibody cetuximab was oc-
casionally utilized with definitive radiation as previously
described [8].
Patient characteristics were compared using the Chi-
square test. All endpoints were calculated from the start
of radiotherapy. Local control (LC), laryngectomy-free
survival (LFS; defined as surviving patients without lar-
yngectomy), laryngo-esophageal dysfunction-free sur-
vival (LEDFS; defined as surviving patients without local
relapse, total or partial laryngectomy, or tracheotomy or
feeding tube at two years or later as previously dis-
cribed [9]), and overall survival (OS) were calculated
using the Kaplan-Meier method with the log rank test
for comparisons. Statistical analyses were performed with
SPSS version 19.0 (IBM Company, New York, USA).
Results
Median follow-up for the 87 eligible patients was 34
months. Patient, tumor, and treatment characteristics
are listed in Table 1. Median RT dose to the gross dis-
ease was 70.2 Gy (range 65.4 – 76.8 Gy). TCCI was
found in 25 (29%) patients, eight with minor TCCI and
17 with major TCCI. The thyroid cartilage alone was
involved in 18 patients, cricoid cartilage alone in two
patients, and both in five patients. All but two cases of
minor TCCI had extension of the primary disease be-
yond the larynx qualifying these tumors as T4.
Local failure occurred in 10 of 62 patients without
TCCI, 1 of 8 patients with minor TCCI, and 6 of
17 patients with major TCCI. Two year LC was 80%
(± 5.8% standard error) without TCCI, 86% (± 13.2%
standard error) with minor TCCI, and 55% (± 13.8%
standard error) with major TCCI (Table 2; p>0.05 for
all comparisons). The patients with no TCCI or minor
TCCI were found to have significantly higher 2 year
LC compared to those with major TCCI (81% vs. 55%,
p=0.045, Figure 2). Within the subset of patients with
T4 disease (43 patients), major cartilage invasion (ver-
sus all other T4 cases) was not significantly associated
with worse LC (55% vs. 78%, p=0.16). The six patients
from the major TCCI group who had local failures did
Table 1 Patient, Tumor, and Treatment characteristics
Characteristic All Patients (n,%) Any Invasion
Total 87 (100) 25 (29)
Gender
Male 68 (78) 19 (76)
Female 19 (22) 6 (24)
Age Median = 57 years
(range 33 – 81)
Median = 58 years
(range 41 – 81)
Ethnicity
Caucasian/Other 49 (56) 13 (52)
African-American 38 (44) 12 (48)
KPS score
50 - 80 73 (84) 21 (84)
90 - 100 14 (16) 4 (16)
Primary site with T-
stage
Larynx 78 (90) 21 (84)
T3 44 (51) 2 (8)
T4a 30 (34) 18 (72)
T4b 4 (5) 1 (4)
Hypopharynx 9 (10) 4 (16)
T4 8 (9) 4(16)
T4b 1 (1) 0 (0)
N-stage
N0 34 (39) 11 (44)
N1 11 (13) 6 (24)
N2 35 (40) 5 (20)
N3 7 (8) 3 (12)
Overall Stage
III 24 (28) 1 (4)
IVA 53 (61) 20 (80)
IVB 10 (11) 4 (16)
Concurrent Therapy
None 9 (10) 2 (8)
Cetuximab 6 (7) 1 (4)
Cytotoxic
Chemotherapy
72 (83) 22 (88)
Neoadjuvant
Chemotherapy
No 75 (86) 21 (84)
Yes 12 (14) * 4 (16)
Fractionation of RT
Conventional 39 (45) 9 (36)
Altered
Fractionation
48 (55) 16 (64)
IMRT
Yes 52 (60) 15 (60)
No 35 (40) 10 (40)
Local Recurrence
Yes 17 (20) 7 (28)
Table 1 Patient, Tumor, and Treatment characteristics
(Continued)
No 70 (80) 18 (72)
Regional
Recurrence




Isolated 2 (40) 0 (0)
No 82 (94) 24 (96)
Distant Metastasis
Yes 16 (18) 4 (16)
No 71 (82) 21 (84)
* 11 of 12 received concurrent chemoradiotherapy after induction and one
received radiotherapy alone.
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a synchronous regional failure) and were able to
undergo salvage laryngectomy. Three of these patients
were without evidence of recurrent disease more than
two years after salvage surgery.
Although major TCCI was associated with decreased
LC, there was no significant difference in rates of
LFS at 2 years. The LFS for major TCCI was 41%
compared to 58% for none/minor TCCI (p=0.31). In
addition, the LEDFS at 2 years for major TCCI was
34% compared to 44% for none/minor TCCI (p = 0.38;
Table 3). As shown in Figure 3, no difference in OS
was found between major TCCI (65%) and no/minor
TCCI (64%).
Discussion
This study of patients with T3/T4 laryngeal cancer and
T4 hypopharyngeal cancer revealed that major TCCI
was a poor prognostic factor regarding LC and not LFS,
LEDFS, or OS. Furthermore, within the subset of T4
tumors, major TCCI was not a significant predictor of
worse LC. However, this latter analysis of T4 patients
was limited due to small numbers of patients in this sub-
group. Our results suggest that it may be reasonable to
offer organ preservation with CRT for motivated patients
with major TCCI. This proposal is based on the fact that
patients who fail organ preservation have good salvage
options and the lack of evidence that upfront surgery
provides improved survival outcomes.
These results are supported by other reports of organ
preservation strategies for advanced laryngeal and hypo-
pharyngeal tumors. For example, Do et al. [10] retro-
spectively analyzed 101 patients with stage T4 head and
neck cancers treated with definitive RT or resection,
from several centers associated with the University of
California Davis. Subset analysis of the CRT group found
no differences in LC (50% and 56% at 5 years,
Table 2 Local Control and Overall Survival at 2 years
# of patients Local control P value Overall Survival P value
All patients 87 76% 64%
Any TCCI 25 65 0.15 64 0.86
No TCCI 62 80 65
Minor TCCI 8 86 0.87 63 0.97
No TCCI 62 80 65
Major TCCI 17 55 0.045 65 0.82
64No or minor TCCI 70 81
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tilage invasion compared to 42 patients with other T4
criteria. The same group later demonstrated no differ-
ence between bone or cartilage invasion [11]. Samant
et al. [12] also reported no difference in outcomes based
on bone versus cartilage invasion in 45 patients treated
with intra-arterial cisplatin and concurrent RT (CRT). In
contrast, Huang et al. [13] reported that patients with
cricoid cartilage invasion had decreased 5 year OS (LC
data not provided) based on multivariate analysis of 47
patients with hypopharyngeal cancer.
Various strategies are currently being tested to
optimize the selection of patients for organ preserva-
tion. The University of Michigan [14] studied the com-
bined results of two phase II trials in 36 patients with
major TCCI by employing a chemoselection regimen.
Treatment with CRT or surgery was determined by re-
sponse to a single cycle of cisplatin and fluorouracil.Figure 2 Kaplan-Meier curves for local control comparing no or mino
patients with no or minor TCCI was 81% compared to 55% with major TCCAfter one cycle of chemotherapy, 81% of patients had
a ≥50% response. These responders underwent CRT
yielding 58% LFS and 78% OS at 3 years. Other
groups have employed this same response-based ap-
proach and have found encouraging results in selective
organ preservation based on restaging biopsies [15,16]
or functional imaging [17] during CRT. Others have
suggested that selection based on initial tumor volume
[18] or pre-treatment laryngeal function [9] may be
reasonable strategies. Further study of these innovative
organ preserving strategies is warranted in the setting
of locoregionally advanced head and neck cancers with
cartilage invasion.
It is noteworthy that TCCI is commonly misdiagnosed
by CT imaging. Beitler et al. [19] compared preoperative
imaging with the results of subsequent surgical path-
ology following laryngectomy. Of the 107 clinically
staged T4 laryngeal tumors, CT imaging correctlyr TCCI (solid) versus major TCCI (dashed). Two-year local control for
I (p=0.045).
Table 3 Organ Preservation at 2 years
Laryngectomy-free survival P value Laryngo-esophageal dysfunction-free survival P value
All patients 55% 41%
Any TCCI 44 0.28 35 0.45
No TCCI 60 44
Minor 50 0.64 38 0.87
No TCCI 60 44
Major TCCI 41 0.31 34 0.38
No or minor TCCI 58 44
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sion without extralaryngeal spread and 49% of cases with
extralaryngeal spread [positive predictive values (PPV)
74% and 81%, respectively]. A similar study by Li et al.
[20] reported only 60% identification of major cartilage
invasion (100% if extralaryngeal spread was present) with
CT imaging. Additionally, 47% of tumors identified as
T4 by CT were downstaged to T3 after pathologic re-
view. Determination of TCCI using MRI may have a
higher detection rate for intracartilagenous invasion but
is a costly and limited resource that is prone to false
positive results [21]. We attempted to minimize our po-
tential misinterpretation of TCCI by excluding findings
of cartilage sclerosis and extralargyngeal spread without
cartilage invasion and by systemically reanalyzing pre-
treatment images.
Our results are subject to the inherent limitations of
any retrospective review. First, only 17 patients hadFigure 3 Kaplan-Meier curves for overall survival comparing overall s
Two-year overall survival for patients with no or minor TCCI was 64% and 6major cartilage invasion. Second, the occasional use of
simulation scans, when diagnostic scans were not avail-
able, may have limited the detection rate of TCCI. Third,
organ preservation therapy precludes pathologic review
as the gold standard for determination of TCCI. With
these noted caveats, the current analysis suggests that
organ preservation strategies can be considered in
patients with TCCI.Conclusions
Major TCCI were associated with decreased LC, but
not LFS, LEDFS, or OS. These patients tend to fail
locally (without distant spread) and are good candi-
dates for salvage surgery. Without a clear survival ad-
vantage to initial surgery in this population, organ
preservation may still be a reasonable treatment
option.urvival for no or minor TCCI (solid) versus major TCCI (dashed).
5% for major TCCI (p=0.82).
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